Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.
    2.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    3.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    4.

    Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.

    Man YG, Gardner WA.

    Med Hypotheses. 2008;70(2):387-408. Epub 2007 Jul 20.

    PMID:
    17658698
    [PubMed - indexed for MEDLINE]
    5.

    Basal epithelial stem cells are efficient targets for prostate cancer initiation.

    Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON.

    Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5. Epub 2010 Jan 25.

    PMID:
    20133806
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.

    Reiner T, de Las Pozas A, Parrondo R, Perez-Stable C.

    Mol Cancer Res. 2007 Nov;5(11):1171-9. Epub 2007 Nov 2.

    PMID:
    17982114
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.

    Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K.

    Am J Pathol. 2011 Jul;179(1):422-35. Epub 2011 May 13.

    PMID:
    21703421
    [PubMed - indexed for MEDLINE]
    9.

    p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.

    Parsons JK, Gage WR, Nelson WG, De Marzo AM.

    Urology. 2001 Oct;58(4):619-24.

    PMID:
    11597556
    [PubMed - indexed for MEDLINE]
    10.

    Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.

    Bonkhoff H, Remberger K.

    Prostate. 1996 Feb;28(2):98-106. Review.

    PMID:
    8604398
    [PubMed - indexed for MEDLINE]
    11.

    Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.

    Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C.

    Histol Histopathol. 2000 Apr;15(2):365-74.

    PMID:
    10809354
    [PubMed - indexed for MEDLINE]
    12.
    13.

    Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.

    Iliopoulos D, Hirsch HA, Wang G, Struhl K.

    Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1397-402. Epub 2011 Jan 10.

    PMID:
    21220315
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.

    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.

    Clin Cancer Res. 2004 Nov 15;10(22):7727-37.

    PMID:
    15570007
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].

    Bonkhoff H, Fixemer T.

    Urologe A. 2004 Jul;43(7):836-42. Review. German.

    PMID:
    15048555
    [PubMed - indexed for MEDLINE]
    16.

    Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.

    Tokar EJ, Diwan BA, Waalkes MP.

    Environ Health Perspect. 2010 Jan;118(1):108-15.

    PMID:
    20056578
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.

    Chauchereau A, Al Nakouzi N, Gaudin C, Le Moulec S, Compagno D, Auger N, Bénard J, Opolon P, Rozet F, Validire P, Fromont G, Fizazi K.

    Exp Cell Res. 2011 Feb 1;317(3):262-75. Epub 2010 Oct 23.

    PMID:
    20974126
    [PubMed - indexed for MEDLINE]
    18.

    Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

    Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

    Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.

    PMID:
    16963837
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Revisiting the concept of cancer stem cells in prostate cancer.

    Wang ZA, Shen MM.

    Oncogene. 2011 Mar 17;30(11):1261-71. Epub 2010 Nov 29. Review.

    PMID:
    21119602
    [PubMed - indexed for MEDLINE]
    20.

    Cell differentiation lineage in the prostate.

    Wang Y, Hayward S, Cao M, Thayer K, Cunha G.

    Differentiation. 2001 Oct;68(4-5):270-9.

    PMID:
    11776479
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Write to the Help Desk